Office of the Director, National Institutes of Health; Notice of Meeting, 67826-67827 [2012-27591]

Agencies

• DEPARTMENT OF HEALTH AND HUMAN SERVICES
• National Institutes of Health

[Federal Register Volume 77, Number 220 (Wednesday, November 14, 2012)]
[Notices]
[Pages 67826-67827]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-27591]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Office of the Director, National Institutes of Health; Notice of 
Meeting

    Pursuant to section 10(a) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of a meeting of the 
Recombinant DNA Advisory Committee.
    The meeting will be open to the public, with attendance limited to 
space available. Individuals who plan to attend and need special 
assistance, such as sign language interpretation or other reasonable 
accommodations, should notify the Contact Person listed below in 
advance of the meeting.

    Name of Committee: Recombinant DNA Advisory Committee
    Date: December 4, 2012.
    Time: 1:50 p.m. to 5:30 p.m.
    Date: December 5, 2012.
    Time: 8:30 a.m. to 3:00 p.m.
    Agenda: The NIH Recombinant DNA Advisory Committee (RAC) will 
discuss selected human gene transfer protocols. Please view the 
meeting agenda at https://oba.od.nih.gov/rdna_rac/rac_meetings.html 
for more information.
    Place: National Institutes of Health, Building 31C, 6th Floor, 
Conference Room 10, 9000 Rockville Pike, Bethesda, MD 20892.
    Contact Person: Chezelle George, Office of Biotechnology 
Activities, Office of Science Policy/OD, National Institutes of 
Health, 6705 Rockledge Drive, Room 750, Bethesda, MD 20892, 301-496-
9838, georgec@od.nih.gov.
    Information is also available on the Institute's/Center's home 
page: https://oba.od.nih.gov/rdna/rdna.html, where an agenda and any 
additional information for the meeting will be posted when 
available.
    OMB's ``Mandatory Information Requirements for Federal 
Assistance Program Announcements'' (45 FR 39592, June 11, 1980) 
requires a statement concerning the official government programs 
contained in the Catalog of Federal Domestic Assistance. Normally 
NIH lists in its announcements the number and title of affected 
individual programs for the guidance of the public. Because the 
guidance in this notice covers virtually every NIH and Federal 
research program in which DNA recombinant molecule techniques could 
be used, it has been determined not to be cost effective or in the 
public interest to attempt to list these programs. Such a list would 
likely require several additional pages. In addition, NIH could not 
be certain that every Federal program would be included as many 
Federal agencies, as well as private organizations, both national 
and international, have elected to follow the NIH Guidelines. In 
lieu of the individual program listing, NIH invites readers to 
direct questions to the information address above about whether 
individual programs listed in the Catalog of Federal Domestic 
Assistance are affected.

[[Page 67827]]

    In the interest of security, NIH has instituted stringent 
procedures for entrance onto the NIH campus. All visitor vehicles, 
including taxicabs, hotel, and airport shuttles will be inspected 
before being allowed on campus. Visitors will be asked to show one 
form of identification (for example, a government-issued photo ID, 
driver's license, or passport) and to state the purpose of their 
visit.
    OBA will offer those members of the public viewing the meeting 
via webcast (see link on OBA Meetings Page) the opportunity to 
submit comments to be read during the scheduled public comment 
periods. Individuals wishing to submit comments should use the 
comment form, which will accommodate comments up to 1500 characters, 
and will be available on the OBA Meetings Page during the meeting. 
Please submit your comment prior to the start of the public comment 
period. Please limit your comment to a statement that can be read in 
one to two minutes. Please include your name and affiliation with 
your comment.
    OBA will read comments into the record during the public comment 
periods that are specified on the agenda. Please note, while every 
effort is made to keep the meeting discussions to the times stated 
on the agenda, it is not unusual for the meeting to run ahead or 
behind schedule due to changes in the time needed to review a 
protocol. It is advisable to monitor the webcast to determine when 
public comments will be read. Comments submitted electronically will 
follow any comments by individuals attending the meeting in person. 
Comments will be read in the order received and your name and 
affiliation will be read with the comment. Please note OBA may not 
be able to read every comment received in the time allotted for 
public comment. Comments not read will become part of the public 
record.
    Any interested person may file written comments with the 
committee by forwarding the statement to the Contact Person listed 
on this notice. The statement should include the name, address, 
telephone number and when applicable, the business or professional 
affiliation of the interested person.

(Catalogue of Federal Domestic Assistance Program Nos. 93.14, 
Intramural Research Training Award; 93.22, Clinical Research Loan 
Repayment Program for Individuals from Disadvantaged Backgrounds; 
93.232, Loan Repayment Program for Research Generally; 93.39, 
Academic Research Enhancement Award; 93.936, NIH Acquired 
Immunodeficiency Syndrome Research Loan Repayment Program; 93.187, 
Undergraduate Scholarship Program for Individuals from Disadvantaged 
Backgrounds, National Institutes of Health, HHS)


    Dated: November 6, 2012.
Carolyn A. Baum,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2012-27591 Filed 11-13-12; 8:45 am]
BILLING CODE 4140-01-P